Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease

Movement Disorders

Volumn 22, Issue 7, 2007, Pages 990-997

  Piboolnurak, Panida ^a,b   Lang, Anthony E ^a   Lozano, Andres M ^c   Miyasaki, Janis M ^a   Saint Cyr, Jean A ^c   Poon, Yu Yan W ^a   Hutchison, William D ^c   Dostrovsky, Jonathan O ^d   Moro, Elena ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b BUMRUNGRAD INTERNATIONAL HOSPITAL   (Thailand)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Deep brain stimulation; Levodopa response; Long term benefit; Parkinson's disease; Subthalamic nucleus

Indexed keywords

LEVODOPA;

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; DAILY LIFE ACTIVITY; DEVICE; DRUG RESPONSE; ELECTRODE; FEMALE; HUMAN; LONG TERM CARE; MALE; OUTCOME ASSESSMENT; PARKINSON DISEASE; PREDICTION; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SUBTHALAMIC NUCLEUS; UNIFIED PARKINSON DISEASE RATING SCALE;

ANTIPARKINSON AGENTS; DEEP BRAIN STIMULATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SUBTHALAMIC NUCLEUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34347237286     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21482     Document Type: Article

References (32)

1. Limousin P, Pollak P, Benazzouz A, et al. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995;345:91-95.
2. Fahn S, Elton RL, and Members of the UPDRS Development Committe. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent developments in Parkinson's disease, Vol. 2. Florham Park, NY: Macmillan Healthcare Information; 1987. p 153-163.
3. Kumar R, Lozano AM, Kim YJ, et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 1998;51:850-855.
4. Moro E, Scerrati M, Romito LM, Roselli R, Tonali P, Albanese A. Chronic subthalamic nucleus stimulation reduces medications requirement in Parkinson's disease. Neurology 1999;53:85-90.
5. Houeto JL, Damier P, Bejjani PB, et al. Subthalamic stimulation in Parkinson disease: a multidisciplinary approach. Arch Neurol 2000;57:461-465.
6. Romito LM, Scerrati M, Contarino MF, Bentivoglio AR, Tonali P, Albanese A. Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease. Neurology 2002;58:1546-1550.
7. Valldeoriola F, Pilleri M, Tolosa E, Molinuevo JL, Rumia J, Ferrer E. Bilateral subthalamic stimulation monotherapy in advanced Parkinson's disease: long-term follow-up of patients. Mov Disord 2002;17:125-132.
8. Vingerhoets FJ, Villemure JG, Temperli P, Polio C, Pralong E, Ghika J. Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up. Neurology 2002;58:396-401.
9. Herzog J, Volkmann J, Krack P, et al. Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease. Mov Disord 2003;18:1332-1337.
10. Kleiner-Fisman G, Fisman DN, Sime E, Saint-Cyr JA, Lozano AM, Lang AE. Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. J Neurosurg 2003;99:489-495.
11. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003;349:1925-1934.
12. Pahwa R, Wilkinson SB, Overman J, Lyons KE. Bilateral subthalamic stimulation in patients with Parkinson disease: long-term follow up. J Neurosurg 2003;99:71-77.
13. Rodriguez-Oroz MC, Zamarbide I, Guridi J, Palmero MR, Obeso JA. Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation. J Neurol Neurosurg Psychiatry 2004;75:1382-1385.
14. Ford B, Winfield L, Pullman SL, et al. Subthalamic nucleus stimulation in advanced Parkinson's disease: blinded assessments at one year follow up. J Neurol Neurosurg Psychiatry 2004;75: 1255-1259.
15. Rodriguez-Oroz MC, Obeso JA, Lang AE, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 2005;128:2240-2249.
16. Ostergaard K, Sunde NA. Evolution of Parkinson's disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus. Mov Disord 2005;21:624-631.
17. Schupbach WMM, Chastan N, Welter ML, et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow-up. J Neurol Neurosurg Psychiatry 2005;76:1640-1644.
18. Saint-Cyr JA, Hoque T, Pereira LC, et al. Localization of clinically effective stimulating electrodes in the human subthalamic nucleus on magnetic resonance imaging. J Neurosurg 2002;97:1152-1166.
19. Nutt JG, Burchiel KJ, Comella CL, et al. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology 2003;60:69-73.
20. Defer GL, Widner H, Marie RM, and the Conference participants. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999;14:572-584.
21. Krack P, Pollak P, Limousin P, et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain 1998;121:451-457.
22. Hilker R, Portman AT, Voges J, et al. Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation. J Neurol Neurosurg Psychiatry 2005;76:1217-1221.
23. Moro E, Esselink RJ, Benabid AL, Pollak P. Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation. Brain 2002;125:2408-2417.
24. Ibanez-Sandoval O, Hernandez A, Floran B, et al. Control of the subthalamic innervation of substantia nigra pars reticulata by D1 and D2 dopamine receptors. J Neurophysiol 2006;95:1800-1811.
25. Rosales MG, Flores G, Hernandes S, Martinez-Fong D, Aceves J. Activation of subthalamic neurons produces NMDA receptor-mediated dendritic dopamine release in substantia nigra pars reticulata: a microdialysis study in the rat. Brain Res 1994;645:335-337.
26. Volkmann J, Allert N, Voges J, Sturm V, Schnitzler A, Freund HJ. Long-term results of bilateral pallidal stimulation in Parkinson's disease. Ann Neurol 2004;55:871-875.
27. Zappia M, Colao R, Montesanti R. et al. Long-duration response to levodopa influences the pharmacodynamics of short-duration response in Parkinson's disease. Ann Neurol 1997;42: 245-248.
28. Lang AE, Obeso JA. Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease. Ann Neurol 2004;55:761-765.
29. Charles PD, Van Blercom N, Krack P, et al. Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology 2002; 59:932-934.
30. Pawha R, Wilkinson SB, Overman J, Lyon KE. Preoperative clinical predictors of response to bilateral subthalamic stimulation in patients with Parkinson's disease. Stereotact Funct Neurosurg 2005;83:80-83.
31. Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006;21 (Suppl. 4):S290-S304.
32. Kleiner-Fisman G, Fisman DN, Zamir O, et al. Subthalamic nucleus deep brain stimulation for Parkinson's disease after successful pallidotomy: clinical and electrophysiological observations. Mov Disord 2004;19:1209-1214.